Session » Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology - Poster II

Date: Tuesday, November 15, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 2703

Apremilast May Improve Atherosclerosis By Promoting Cholesterol Efflux and Inhibiting Foam Cell Formation in Atherosclerotic Plaques

9:00AM-11:00AM: Abstract Number: 2714

Association of Polymorphisms of Activation-Induced Cytidine Deaminase with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 2707

Autoantibodies Against CD74 – a New Diagnostic Marker for Spondyloarthritis (SpA)

9:00AM-11:00AM: Abstract Number: 2710

Bacterial Dysbiosis Associates with Functional Intraepithelial Lymphocyte Changes in Inflammatory Bowel Disease and Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 2705

Decreased Expression of Autophagy Genes and Their Association with Spinal Damage in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 2713

Differentially Expressed Microrna As Candidate Biomarker for Disease Activity in Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 2704

Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04755) As a Potential Topical Treatment for Psoriasis

9:00AM-11:00AM: Abstract Number: 2719

Discriminating Value of Calprotectin in Disease Activity and Progression of Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 2716

Does Secretory Immunoglobulin a Influence Disease Activity in Patients with Reactive Arthritis and Undifferentiated Spondylarthritis?

9:00AM-11:00AM: Abstract Number: 2706

Elevated Levels of Serum Myeloid Related Protein 8/14 in Ankylosing Spondylitis: Associated with Peripheral Arthritis and Active Disease

9:00AM-11:00AM: Abstract Number: 2695

Genetic Association of Ankylosing Spondylitis with TBX21 Influences T-Bet and Pro-Inflammatory Cytokine Expression in Humans and SKG Mice As a Model of Spondyloarthritis and Alters Host Microbiome and Response to Microbial Stimuli

9:00AM-11:00AM: Abstract Number: 2715

Genetic Variants in TNF, TNFRSF1A, and IL23R Are Associated with Risk of Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 2720

Genome-Wide Association Study of Clinical Phenotypes in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 2696

Identification of a Potential Commensal Immunologic Target in Enthesitis-Related Arthritis

9:00AM-11:00AM: Abstract Number: 2701

Increased Frequency of Regulatory CD19+CD24high Cd38high B Cells in Patients with Ankylosing Spondylitis (AS)

9:00AM-11:00AM: Abstract Number: 2712

Inverse Correlation Between IL-10-Producing Bregs and IFN-Gamma-Producing NK Cells in Psoriatic Arthritis and Psoriasis

9:00AM-11:00AM: Abstract Number: 2697

Modulator Role of Inducible Costimulator (ICOS) in Spondyloarthritis Animal Model

9:00AM-11:00AM: Abstract Number: 2718

Plasma Levels of the M2 Macrophage Markers, CD163 and CD206, Changes Reversely and Soluble CD163 Is Associated with Disease Activity in Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 2698

Regulation of Inflammation By Interleukin-27 in a Rat Model of Spondyloarthritis (SpA)

9:00AM-11:00AM: Abstract Number: 2717

Sclerostin and Dickkopf-1 but Not Periostin May Have a Role in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 2699

Spa-Associated HLA-B*27 Subtypes Accumulate More in Endoplasmic Reticulum (ER) Compartment and in Association with β2-Microglobulin (β2m) Than Non-Associated HLA-B Alleles

9:00AM-11:00AM: Abstract Number: 2702

Taking Fly for Understanding the Molecular Role of HLA-B27/hB2m in Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 2700

The Lymphatic System: A Gatekeeper for Migration of Pathogenic T-Cells Towards Synovial Joints and Entheses in Psoriasis

9:00AM-11:00AM: Abstract Number: 2711

Tissue-Resident IL-23 Responsive Innate T Cells in Mice Comprise Tcrαβ+ and TCRγδ+ Subsets with Overlapping Function

9:00AM-11:00AM: Abstract Number: 2694

Treatment of ZAP-70 Mutant SKG Mice with Anti-IL-23 Antibody Alters Fecal Microbiota Composition and Prevents Outgrowth of Bacteria Associated with Susceptibility to Spondyloarthritis and Ileitis

9:00AM-11:00AM: Abstract Number: 2708

Type 17 Immunity in Spondyloarthritis Is Expanded Across Multiple Lymphocyte Subsets

9:00AM-11:00AM: Abstract Number: 2709

Which Cells Correspond to the Typical Signals for Fatty and Inflammatory Lesions Seen in Magnetic Resonance Imaging in Ankylosing Spondylitis ? -a Prospective Study Using Biopsy Material Obtained during Spinal Surgery-

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].